Profile data is unavailable for this security.
About the company
YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the wholesaling and trading of pharmaceuticals. The Company distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)2.27bn
- Net income in CNY222.85m
- Incorporated1999
- Employees3.61k
- LocationYabao Pharmaceutical Group Co LtdNo.1Gongye BoulevardFenglingdu Economic Development ZoneBEIJING 100176ChinaCHN
- Phone+86 1 057809936
- Fax+86 1 057809937
- Websitehttp://www.yabao.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jinyao Pharmaceutical Co Ltd | 2.87bn | 16.30m | 4.54bn | 2.88k | 272.43 | 1.50 | -- | 1.58 | 0.0153 | 0.0153 | 2.63 | 2.77 | 0.49 | 2.45 | 6.38 | 996,743.00 | 1.39 | 1.87 | 2.18 | 3.31 | 41.43 | 45.67 | 2.84 | 3.30 | 1.19 | 11.91 | 0.1563 | 65.00 | -15.00 | -0.6786 | 14.01 | -3.78 | -23.40 | 19.63 |
| Zhejiang Starry Pharmaceutical Co Ltd | 2.39bn | -29.25m | 4.57bn | 1.75k | -- | 1.76 | -- | 1.91 | -0.1149 | -0.1149 | 5.84 | 5.93 | 0.4078 | 1.78 | 5.62 | 1,363,012.00 | -0.4978 | 2.04 | -0.8498 | 3.75 | 18.98 | 27.73 | -1.22 | 5.05 | 0.4035 | 0.6728 | 0.5007 | 78.73 | 7.02 | 12.42 | -211.00 | -- | 29.24 | -3.43 |
| Yabao Pharmaceutical Group Co Ltd | 2.27bn | 222.85m | 4.58bn | 3.61k | 20.84 | 1.66 | -- | 2.02 | 0.3177 | 0.3177 | 3.26 | 3.99 | 0.6462 | 3.42 | 6.66 | 629,532.00 | 5.51 | 4.01 | 6.54 | 5.38 | 50.46 | 56.75 | 8.53 | 5.86 | 2.49 | -- | 0.0418 | 54.27 | -7.69 | -2.46 | 21.60 | 77.16 | -26.08 | 71.88 |
| Obio Technology Shanghai Corp Ltd | 244.64m | -294.16m | 4.60bn | 692.00 | -- | 3.02 | -- | 18.81 | -0.4578 | -0.4578 | 0.3819 | 2.35 | 0.1095 | 4.22 | 2.37 | 353,519.30 | -13.15 | -3.10 | -15.68 | -3.47 | -37.29 | 19.60 | -120.16 | -23.22 | 1.06 | -94.99 | 0.2068 | -- | 21.16 | 31.58 | -151.54 | -- | 36.17 | -- |
| Sinotherapeutics Inc | 480.48m | 98.59m | 4.63bn | 312.00 | 46.95 | 3.54 | -- | 9.63 | 0.2175 | 0.2175 | 1.06 | 2.89 | 0.333 | 2.74 | 4.51 | 1,539,987.00 | 6.83 | 10.22 | 7.32 | 11.26 | 43.78 | 65.76 | 20.52 | 31.88 | 11.08 | -- | 0.00002 | 13.77 | 70.61 | 29.80 | 109.09 | 94.07 | 32.01 | -- |
| Ningbo Menovo Pharmaceutical Co Ltd | 1.54bn | 99.48m | 4.67bn | 2.47k | 47.05 | 2.02 | -- | 3.03 | 0.4502 | 0.4502 | 7.00 | 10.49 | 0.329 | 1.23 | 5.91 | 623,207.90 | 2.34 | 3.98 | 3.68 | 6.21 | 32.03 | 34.08 | 7.11 | 12.00 | 0.7165 | 5.71 | 0.3482 | 11.27 | 12.85 | 3.07 | 476.64 | -15.04 | -11.37 | -8.68 |
| Shanghai Xiao Fang Pharmaceutical Co Ltd | 504.59m | 213.50m | 4.76bn | 404.00 | 22.17 | 4.51 | -- | 9.43 | 1.33 | 1.33 | 3.16 | 6.57 | 0.3795 | 3.71 | 4.85 | 1,248,981.00 | 16.06 | -- | 19.02 | -- | 65.40 | -- | 42.31 | -- | 3.47 | -- | 0.0017 | -- | 0.5748 | -- | 0.8074 | -- | -- | -- |
| Pulike Biological Engineering Inc | 1.10bn | 143.67m | 4.78bn | 1.55k | 32.87 | 1.86 | -- | 4.33 | 0.4204 | 0.4204 | 3.22 | 7.45 | 0.3571 | 2.68 | 3.03 | 711,690.80 | 4.65 | 6.79 | 5.41 | 8.00 | 57.65 | 62.55 | 13.02 | 16.34 | 2.51 | 15.83 | 0.0005 | 61.54 | -16.77 | 9.47 | -46.82 | -3.21 | 7.28 | 14.87 |
| Tibet Weixinkang Pharmaceutical Co Ltd | 1.17bn | 222.08m | 4.84bn | 689.00 | 21.67 | 3.17 | -- | 4.15 | 0.5136 | 0.5136 | 2.71 | 3.51 | 0.608 | 11.75 | 6.71 | 1,695,637.00 | 11.56 | 10.05 | 14.30 | 13.45 | 58.42 | 51.50 | 19.01 | 13.72 | 3.93 | -- | 0.0058 | 52.31 | -1.69 | 11.90 | 15.02 | 34.62 | 5.91 | 50.02 |
| Guizhou Sanli Pharmaceutical Co Ltd | 1.74bn | 160.68m | 4.90bn | 2.85k | 30.19 | 3.32 | -- | 2.82 | 0.3969 | 0.3969 | 4.26 | 3.61 | 0.5877 | 1.73 | 2.98 | 608,615.00 | 5.58 | 10.78 | 8.75 | 15.70 | 68.09 | 70.69 | 9.49 | 15.41 | 1.11 | 27.57 | 0.345 | 35.70 | 31.16 | 19.40 | -6.38 | 15.54 | 41.35 | -- |
Data as of Feb 13 2026. Currency figures normalised to Yabao Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 3.24m | 0.42% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.80m | 0.36% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 2.26m | 0.29% |
| Gfund Management Co., Ltd.as of 30 Jun 2025 | 1.85m | 0.24% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 1.81m | 0.24% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 1.34m | 0.17% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 318.00k | 0.04% |
| Chang Xin Asset Management Co., Ltd.as of 30 Jun 2025 | 282.10k | 0.04% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2025 | 270.60k | 0.04% |
| FIL Investments Internationalas of 30 Jun 2025 | 259.20k | 0.03% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
